HW
Hans Lennart Rudolf Wigzell

Hans Lennart Rudolf Wigzell insider trades: Sarepta Therapeutics (SRPT) stock sales

Sarepta Therapeutics Last trade Dec 12, 2024 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2017
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hans reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 12, 2024SRPT↓ Sell$1.3M
Mar 8, 2024SRPT↓ Sell$1.8M
Aug 4, 2023SRPT↓ Sell$1.6M
Mar 8, 2021SRPT↓ Sell$835K
Aug 10, 2020SRPT↓ Sell$1.6M
May 20, 2020SRPT↓ Sell$753K
Mar 4, 2020SRPT↓ Sell$584K
May 23, 2019SRPT↓ Sell$1.2M
Nov 1, 2018SRPT↓ Sell$937K
Nov 30, 2017SRPT↓ Sell$373K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SRPT insiders

Open-market trades in the last 12 months

About Hans Lennart Rudolf Wigzell's insider trades

Hans Lennart Rudolf Wigzell is an insider at Sarepta Therapeutics (SRPT). Since Nov 30, 2017, Hans has reported no open-market purchases and 10 sales worth $11.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.